Pharmaxis Of Australia Presses Case For EU CF-Drug Approval
This article was originally published in PharmAsia News
Executive Summary
Australia's Pharmaxis is counting heavily on European Union approval of the firm's Bronchitol (mannitol) for treating cystic fibrosis, and the CEO says he is confident